<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>12(1)</volume><submitter>Gal Etzioni TR</submitter><pubmed_abstract>Invasive fungal infections (IFI) cause morbidity and mortality in children with acute leukemia (AL). We retrospectively collected data on febrile neutropenic episodes (FNE) in AL children (2016-2021) and assessed factors associated with proven/probable IFI. Ninety-three children developed 339 FNE. Seventeen (18.3%) children developed 19 proven/probable IFI (11 yeast; eight molds). The proven/probable yeast IFI rate was 6/52 (11.5%) in children who belong to the high risk for IFI category (HR-IFI-AL: high-risk acute lymphocytic leukemia (ALL), acute myeloid leukemia, relapse); and 5/41 (12.2%) in the non-HR-IFI-AL category (standard/intermediate risk ALL). The proven/probable mold IFI rate was 7/52 (13.5%) in HR-IFI-AL children and 1/41 (2.4%) in the non-HR-IFI-AL category. In the multivari</pubmed_abstract><journal>Microorganisms</journal><pagination>145</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10820110</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Invasive Fungal Infections in Children with Acute Leukemia: Epidemiology, Risk Factors, and Outcome.</pubmed_title><pmcid>PMC10820110</pmcid><pubmed_authors>Korem M</pubmed_authors><pubmed_authors>Gal Etzioni TR</pubmed_authors><pubmed_authors>Nitzan-Luques A</pubmed_authors><pubmed_authors>Temper V</pubmed_authors><pubmed_authors>Averbuch D</pubmed_authors><pubmed_authors>Goldstein G</pubmed_authors><pubmed_authors>Fainshtain N</pubmed_authors><pubmed_authors>Weinreb S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Invasive Fungal Infections in Children with Acute Leukemia: Epidemiology, Risk Factors, and Outcome.</name><description>Invasive fungal infections (IFI) cause morbidity and mortality in children with acute leukemia (AL). We retrospectively collected data on febrile neutropenic episodes (FNE) in AL children (2016-2021) and assessed factors associated with proven/probable IFI. Ninety-three children developed 339 FNE. Seventeen (18.3%) children developed 19 proven/probable IFI (11 yeast; eight molds). The proven/probable yeast IFI rate was 6/52 (11.5%) in children who belong to the high risk for IFI category (HR-IFI-AL: high-risk acute lymphocytic leukemia (ALL), acute myeloid leukemia, relapse); and 5/41 (12.2%) in the non-HR-IFI-AL category (standard/intermediate risk ALL). The proven/probable mold IFI rate was 7/52 (13.5%) in HR-IFI-AL children and 1/41 (2.4%) in the non-HR-IFI-AL category. In the multivari</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Jan</publication><modification>2025-04-21T15:56:14.073Z</modification><creation>2025-04-21T15:56:14.073Z</creation></dates><accession>S-EPMC10820110</accession><cross_references><pubmed>38257971</pubmed><doi>10.3390/microorganisms12010145</doi></cross_references></HashMap>